Stocks and Investing
Stocks and Investing
Wed, January 4, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (CABA) at Buy with Increased Target to $14 on, Jan 3rd, 2023
Derek Archila of Wells Fargo, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Increased Target from $4 to $14 on, Jan 3rd, 2023.
Derek has made no other calls on CABA in the last 4 months.
There is 1 other peer that has a rating on CABA. Out of the 1 peers that are also analyzing CABA, 0 agree with Derek's Rating of Hold.
This is the rating of the analyst that currently disagrees with Derek
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $12 on, Friday, November 11th, 2022
Contributing Sources